SHL Telemedicine H1 EPS $(0.24) Up From $(0.25) YoY, Sales $27.90M Down From $29.00M YoY
SHL Telemedicine H1 EPS $(0.24) Up From $(0.25) YoY, Sales $27.90M Down From $29.00M YoY
SHL遠程醫療上半年每股收益爲$(0.24),較上年同期$(0.25)有所增長,銷售額爲2790萬美元,較上年同期2900萬美元有所下降。
SHL Telemedicine (NASDAQ:SHLT) reported quarterly losses of $(0.24) per share. This is a 4 percent increase over losses of $(0.25) per share from the same period last year. The company reported $27.90 million in sales this quarter. This is a 3.81 percent decrease over sales of $29.00 million the same period last year.
SHL遠程醫療(納斯達克:SHLT)報告本季度每股虧損$(0.24)。這比去年同期每股虧損$(0.25)增加了4%。公司本季度銷售額爲2790萬美元。這比去年同期的銷售額2900萬美元減少了3.81%。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。